Agilent Press ConferenceJune 6, 2016

Powerful

Partnerships.

Inspiring Outcomes

Safe HarborThis presentation contains forward-looking statements (including, without limitation, information and future guidance on the company’s goals, priorities, growth opportunities, financial performance and condition, including revenue growth, operating margin, free cash flow, earnings and capital allocation and deployment, the continued strengths and expected growth of the markets the company sells into, customer service and innovation plans, new product introductions, infrastructure and supply chain optimization, and operations) that involve risks and uncertainties that could cause results of Agilent to differ materially from management’s current expectations. The words “anticipate,” “plan,” “estimate,” “expect,” “intend,” “will,” “should” “forecast” “project” and similar expressions, as they relate to the company, are intended to identify forward-looking statements.

In addition, other risks that the company faces in running its operations include the ability to execute successfully through business cycles; the ability to successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross margin pressures; the risk that our cost-cutting initiatives will impair our ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties on our markets and our ability to conduct business; the impact of currency exchange rates on our financial results; the ability to improve asset performance to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; and other risks detailed in the company's filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q for the quarter ended April 30, 2016.

The company assumes no obligation to update the information in these presentations. These presentations and the Q&A that follows include non-GAAP measures. Non-GAAP measures exclude primarily the impacts of acquisition and integration costs, future restructuring costs, transformational initiatives, asset impairment charges, business exit costs and divestiture, and non-cash intangibles amortization. Also excluded are tax benefits that are not directly related to ongoing operations and which are either isolated or cannot be expected to occur again with any regularity or predictability. Most of these excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy. Accordingly, no reconciliation to GAAP amounts has been provided.

.

Powerful Partnerships. Inspiring Outcomes.

Monty BenefielVice President /General Manager

Agilent Mass Spec Division

Jim YanoVice President, Marketing

Agilent Mass Spec Division

Agilent at ASMS 2016

What Makes Agilent

A Great Partner

It’s About Mass Spectrometry But More than the Mass Spec

It’s About Better ChromatographySystems and Consumables

Routine analysis to

cutting-edge research

Broadest portfolio of LC

systems and solutions

Bringing more efficiency into

the analytical lab

Outstanding value proposition for upgrades and replacements

New 1260 Infinity

II HPLC

It’s Definitely About More than Peaks and Spectra

It’s About Sample PreparationIncluding Automation

Agilent Serves the Entire Analytical LabAnticipating and responding quickly to customer needs

Bioreagents

Chemistries & supplies

FISH probes

Immunohistochemistry

Informatics

Vacuum

CrossLab

Consumables

CrossLab

Services

OpenLAB

Software Platform

HPLC

GC

Mass Spec

Spectroscopy

Automation

Microarrays

Target enrichment

Agilent Technologies Receives Award for Outstanding Customer Service for Second Straight Year

Powerful

Partnerships.

Inspiring

Outcomes

YES!

SANTA CLARA, Calif.--(BUSINESS WIRE)--

Agilent Technologies Inc. (NYSE:A) today

announced it has been recognized with the 2016

Reviewers’ Choice Award for Customer Service

from SelectScience, an independent, expert-led

scientific review.

This is the second year in a row that SelectScience

reviewers, which include scientists around the world,

judged Agilent’s customer service to be the best in

the laboratory products industry.

Agilent Technologies Inc.

March 17, 2016 11:00 AM

Our Partnership Is Focused on Their Complete Workflow

Our Customers Are Focused

on Their Molecules

Our Partnership Is Focused on Their Workflow

Sample Preparation

Chromatographic Separation

Mass Spectrometry

Software, software, software

Services

Our Customers Are Focused

on Their Molecules

Environment FoodChemical

& Energy PharmaAcademia &

Government

Clinical &

DiagnosticsThe

$45BOpportunity $13B(1) $10B(1)$22B(1)

Agilent’s Winning Strategy The World’s Premier Laboratory Partner

(1) Market sizes per Company estimates

(1)

Inspiring Greater and Better Outcomes for Our Customers

Seahorse Extracellular Flux Analyzer

Mitochrondrial fuel usage

Cell energy phenotype test

Mitochrondrial stress test

Glycolysis stress test

all in live cells

Cell Metabolism Measurements: Seahorse & MS Enabling breakthroughs in cancer research

Agilent is a leader in Metabolomics

Strong software suite and Mass Spectrometry platforms

Seahorse acquisition strengthens our Metabolomics leadership

Highly differentiated live cell metabolism measurements

The combination of these research platforms enable major discoveries

For example in cancer research

&

Agilent at ASMS 2016Powerful partnerships. Inspiring results.

Saturday, June 4 Reception

Integrating Metabolite Profiles

for Less Impersonal Medicine

Breakout Sessions conducted by

Agilent customers

Track 1: Biological Research

Track 2: Pharma/BioPharma

Track 3: Applied Markets including Food

& Environmental

Visit the Agilent Booth #200

June 6 - 8 Breakfast Workshops

June 6: Expand Your Metabolomics Horizons

June 7: Better, Faster Agilent Solutions for

Biopharmaceutical Characterization

June 8: Food for Mass Spec Thought in the Applied

Markets

Daily 8am-11pm Agilent Hospitality Suite

Grand Hyatt

Keynote speaker:

Dr. Robert Gerszten

Chief of Cardiology

Beth Israel Deaconess

Medical Center

Inspiring Outcomes

MD Anderson

Cancer CenterJennifer Molina & Pietro Morlacchi

Nagoya Institute

of TechnologyProfessor Hajime Ohtani

Seahorse & LC/MSGC/MS

Agilent Confidential Sept. 2014 Board Meeting

18

What Are We

Delivering to

Our Lab Partners

This Year?

Cellular

Metabolism

Molecular

Metabolism

Understand Cellular and Molecular MetabolismAgilent Seahorse and Mass Spectrometry Together

For Research Use Only. Not for use in diagnostic procedures.

Metabolomics:Accelerate Your Research With VistaFlux! Agilent’s Qualitative Flux Analysis Workflow

For Research Use Only. Not for use in diagnostic procedures.

Create Target

Metabolite List

Acquire Data

Extract Features

Visualize on

Pathways• Pathways

to PCDL

• PCDL

Manager

• MassHunter

Acquisition

• LC/TOF or

LC/Q-TOF

• Profinder

with

VistaFlux

• Omix

Premium

VistaFlux Workflow

Flux Experiment Done by Justin CrossCancer Cell Line with Enzyme Mutation (IDH2)

Goal: Understand impact of

mutation on glutamate

metabolism

Tracer experiment with

U-13C-Glutamine (Gln)

Monitoring metabolites

labeled in

green

Figure courtesy of Justin Cross, Donald B. and

Catherine C. Marron Cancer Metabolism Center,

Memorial Sloan Kettering Cancer Center

For Research Use Only. Not for use in diagnostic procedures.

Metabolomics dMRM Database and MethodIntegrated with Agilent’s Metabolomics Workflows

DataAcquisition

&Analysis

QuantitationSeparate & Detect

StatisticsPathways

LC/MS/MS MassHunter

Mass Profiler

ProfessionalPathway Architect

For Research Use Only. Not for use in diagnostic procedures.

Dynamic MRM Database

covers >215 central carbon

metabolites

Designed for 1290 Infinity II

and 6460/6470 Triple

Quadrupole MS

Provides an optimized

method and database with

stable, robust

chromatography

BioPharma: ADC DAR MassHunter WalkupDrug-Antibody Ratio for Reduced and Intact ADCs

Non-expert LC/MS users can easily submit samples in MassHunter

Walkup - completes Agilent’s suite of products for an accelerated ADC

characterization workflow

Pharma: Expanding Extractables & Leachables

Complements

GC/MS and ICP-

MS solutions

Confirmation of product purity

> 800 compounds

> 300 with exact mass

Integrated into the All Ions workflow

6200 Series TOF & 6500 Series Q-TOF with

1260/1290 Infinity II LC Series

Proteomics: AssayMAP Bravo Target Customer

Digest Desalt Enrich Elute Clean up Analyze

DigestPurify Desalt Clean up Analyze

• Scalable

• Reproducible

• EfficientAlkylate

Phosphopeptide Enrichment

Rapid Protein Digest

Food: Safety in Numbers (Because More Matters)

LC/TOF & LC/Q-TOF PCDLs

> 1700 Pesticides

> 2100 Veterinary Drugs

> 450 Mycotoxins

Free upgrades for 3 years

Environmental: Addressing Regulatory Requirements

New LC/MS

Analyzer

New GC/MS

Analyzer

Water Screening PCDL

Covers US, EU, China & Japan

regulations

> 1,400 compounds

> 1,000 with exact mass 6200 Series TOF

& 6500 Series Q-TOF

Complements GC/MS and ICP-MS solutions

Water Pollutant Screener

Report templates compliant with

European Water Framework Directive

2000/60/EC

> 1,000 compound database

with spectra and retention time

5977B Series GC/MSD (SQ)

GC/MS EI Source That Cleans Itself

JetCleanConsistent response for weeks or months or years

No downtime for source maintenance

Available as an option or included with factory tested analyzers

Patented

Chemicals: Arsine/Phosphine Analyzer

PE + PP >130 MMT

In 2015

5977B GC/SQ

HES: High Efficiency On-axis EI

JetClean

Arsine/Phosphine Analyzer

Protecting catalyst efficiency for

polyethylene and polypropylene

production

> Single digit ppb detection

300 runs, 4.6 days with % RSDs < 5%

The New Agilent 8900 Triple Quadrupole ICP-MS

Superior Performance

Controlled reaction chemistry for

consistent, reliable results

Resolution of isobaric overlaps (beyond

capability of high-resolution ICP-MS)

Lowest detection limits, even for

previously “difficult” elements: S, Si, P…

Unparalleled Flexibility

4-channel cell gas control as standard

Unique precursor/product ion scan modes

clarify reaction processes

LEAVE INTERFERENCES BEHIND WITH MS/MS

Time for YOUR technology refresh!

Leveraging 1290 Infinity II LC technologies for customer benefits!

The new Agilent 1260 Infinity II LC!

Isocratic, Quaternary and Binary

InfinityLab Columns InfinityLab Parts

Poroshell

Better in Every Way• Sampling

• Solvent delivery

• Column handling

• Detection limits

• Ergonomics & safety

• Fully bio-inert

• Fully backwards method compatibility

Inspiring Outcomes

MD Anderson

Cancer CenterJennifer Molina & Pietro Morlacchi

Nagoya Institute

of TechnologyProfessor Hajime Ohtani

University of

ArizonaProfessor Shane Snyder

Seahorse & LC/MSGC/MS LC/MS, GC/MS &

ICP-MS

Agilent’s Partnership Goal

Supplies Software Applications CrossLab

Any Analyte Any Method One Partner

Focus is always the

customer

Emphasis on

solutions for the

customer’s

workflow . . . not

just mass

spectrometers

“

“

Mass SpecSeparationsAutomations

Thank You